BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 12778877)

  • 1. [Survival of myeloma patients treated with dialysis].
    Martín Reyes G; Valera A; Frutos MA; Ramos B; Ordóñez V; López de Novales E
    Nefrologia; 2003; 23(2):131-6. PubMed ID: 12778877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staff-assisted nursing home haemodialysis: patient characteristics and outcomes.
    Reddy NC; Korbet SM; Wozniak JA; Floramo SL; Lewis EJ
    Nephrol Dial Transplant; 2007 May; 22(5):1399-406. PubMed ID: 17259652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment.
    Iggo N; Palmer AB; Severn A; Trafford JA; Mufti GJ; Taube D; Parsons V
    Q J Med; 1989 Oct; 73(270):903-10. PubMed ID: 2629022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
    Abbott KC; Agodoa LY
    Clin Nephrol; 2001 Sep; 56(3):207-10. PubMed ID: 11597035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of serum albumin and phosphorous as predictors of mortality in ESRD patients.
    Phelan PJ; O'Kelly P; Walshe JJ; Conlon PJ
    Ren Fail; 2008; 30(4):423-9. PubMed ID: 18569917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dialyzer membrane permeability and survival in hemodialysis patients.
    Chauveau P; Nguyen H; Combe C; Chêne G; Azar R; Cano N; Canaud B; Fouque D; Laville M; Leverve X; Roth H; Aparicio M;
    Am J Kidney Dis; 2005 Mar; 45(3):565-71. PubMed ID: 15754279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutritional status evaluation and survival in haemodialysis patients in one centre from Romania.
    Segall L; Mardare NG; Ungureanu S; Busuioc M; Nistor I; Enache R; Marian S; Covic A
    Nephrol Dial Transplant; 2009 Aug; 24(8):2536-40. PubMed ID: 19297358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and treatment of renal insufficiency in multiple myeloma].
    Mølby L; Hansen HH; Jensen EL
    Ugeskr Laeger; 1994 Jul; 156(30):4343-7. PubMed ID: 8066935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous veno-venous hemofiltration in Bhumibol Adulyadej Hospital.
    Chuasuwan A; Gojaseni P; Chittinandana A
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S86-97. PubMed ID: 17044459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma--presenting as acute kidney injury.
    Prakash J; Niwas SS; Parekh A; Vohra R; Wani IA; Sharma N; Usha
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe renal failure in multiple myeloma.
    Cosio FG; Pence TV; Shapiro FL; Kjellstrand CM
    Clin Nephrol; 1981 Apr; 15(4):206-10. PubMed ID: 7237869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of acute renal failure due to myeloma kidney.
    Bear RA; Cole EH; Lang A; Johnson M
    Can Med Assoc J; 1980 Oct; 123(8):750-3. PubMed ID: 7004618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Acute and chronic renal failure in patients with myeloma].
    Biriukova LS; Volodiaeva EB; Fetisova EV; Pivnik AV; Margolin OV
    Ter Arkh; 1999; 71(7):58-64. PubMed ID: 10481869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflection point of ascending aortic waveform is a predictive factor for all-cause and cardiovascular mortality in patients with chronic renal failure on hemodialysis.
    Ueda H; Hayashi T; Tsumura K; Yoshimaru K; Nakayama Y; Yoshikawa J
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1151-5. PubMed ID: 15607622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Late nephrology referral influences on morbidity and mortality of hemodialysis patients. A provincial study].
    Peña JM; Logroño JM; Pernaute R; Laviades C; Virto R; Vicente de Vera C
    Nefrologia; 2006; 26(1):84-97. PubMed ID: 16649429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. End-stage renal disease patients on renal replacement therapy in the intensive care unit: short- and long-term outcome.
    Bell M; Granath F; Schön S; Löfberg E; ; Ekbom A; Martling CR
    Crit Care Med; 2008 Oct; 36(10):2773-8. PubMed ID: 18766088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.